Invitrogen launched an exciting new products based on the patent-protected ChargeSwitch nucleic acid purification technology earlier this year. Invitrogens new ChargeSwitch technology can be used with either DNA or RNA in a range of formats, and includes simple manual purification of a few samples as well as high throughput automated applications. ChargeSwitch requires just three simple steps to extract nucleic acids from a wide variety of sources, including bacteria, tissues, blood, forensic sample and buccal cells, and excels on small sample sizes. Unlike other DNA/RNA purification methods, ChargeSwitch is 100 percent water-based and does not need hazardous or caustic chemicals, which are known to compromise the efficiency of many downstream processes such as PCR and their absence in ChargeSwitch-based protocols, can offer significant performance benefits. |
to send to friends
